nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP2D6—breast cancer	0.186	0.538	CbGaD
Prochlorperazine—CYP3A4—breast cancer	0.16	0.462	CbGaD
Prochlorperazine—Promazine—Tamoxifen—breast cancer	0.0568	1	CrCrCtD
Prochlorperazine—CYP3A4—Exemestane—breast cancer	0.0361	0.103	CbGbCtD
Prochlorperazine—CYP2D6—Idarubicin—breast cancer	0.0326	0.093	CbGbCtD
Prochlorperazine—CYP3A4—Letrozole—breast cancer	0.0307	0.0876	CbGbCtD
Prochlorperazine—CYP3A4—Anastrozole—breast cancer	0.0274	0.0781	CbGbCtD
Prochlorperazine—CYP3A4—Toremifene—breast cancer	0.025	0.0714	CbGbCtD
Prochlorperazine—CYP3A4—Fulvestrant—breast cancer	0.0233	0.0664	CbGbCtD
Prochlorperazine—CYP3A4—Thiotepa—breast cancer	0.0207	0.0592	CbGbCtD
Prochlorperazine—CYP3A4—Ixabepilone—breast cancer	0.019	0.0541	CbGbCtD
Prochlorperazine—CYP3A4—Lapatinib—breast cancer	0.0183	0.0521	CbGbCtD
Prochlorperazine—CYP2D6—Vinorelbine—breast cancer	0.0159	0.0454	CbGbCtD
Prochlorperazine—CYP2D6—Tamoxifen—breast cancer	0.0144	0.041	CbGbCtD
Prochlorperazine—CYP3A4—Raloxifene—breast cancer	0.0138	0.0395	CbGbCtD
Prochlorperazine—CYP3A4—Vinorelbine—breast cancer	0.0101	0.0289	CbGbCtD
Prochlorperazine—CYP2D6—Vinblastine—breast cancer	0.00981	0.028	CbGbCtD
Prochlorperazine—CYP3A4—Tamoxifen—breast cancer	0.00914	0.0261	CbGbCtD
Prochlorperazine—CYP3A4—Mitoxantrone—breast cancer	0.00891	0.0254	CbGbCtD
Prochlorperazine—CYP3A4—Paclitaxel—breast cancer	0.00711	0.0203	CbGbCtD
Prochlorperazine—CYP3A4—Irinotecan—breast cancer	0.00702	0.02	CbGbCtD
Prochlorperazine—CYP3A4—Vinblastine—breast cancer	0.00624	0.0178	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—breast cancer	0.00603	0.0172	CbGbCtD
Prochlorperazine—CYP3A4—Docetaxel—breast cancer	0.00514	0.0147	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—breast cancer	0.00383	0.0109	CbGbCtD
Prochlorperazine—Trifluoperazine—S100A4—breast cancer	0.00064	0.153	CrCbGaD
Prochlorperazine—Ethopropazine—BCHE—breast cancer	0.000154	0.0367	CrCbGaD
Prochlorperazine—Hydroxyzine—CYP2D6—breast cancer	0.000133	0.0316	CrCbGaD
Prochlorperazine—Clomipramine—GSTP1—breast cancer	0.000129	0.0308	CrCbGaD
Prochlorperazine—Triflupromazine—BCHE—breast cancer	0.000126	0.0301	CrCbGaD
Prochlorperazine—Headache—Vinblastine—breast cancer	9.86e-05	0.000525	CcSEcCtD
Prochlorperazine—Angioedema—Paclitaxel—breast cancer	9.85e-05	0.000525	CcSEcCtD
Prochlorperazine—Hypotension—Gemcitabine—breast cancer	9.82e-05	0.000523	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—breast cancer	9.78e-05	0.000521	CcSEcCtD
Prochlorperazine—Insomnia—Irinotecan—breast cancer	9.75e-05	0.00052	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—breast cancer	9.73e-05	0.000518	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—breast cancer	9.7e-05	0.000517	CcSEcCtD
Prochlorperazine—Dizziness—Goserelin—breast cancer	9.65e-05	0.000514	CcSEcCtD
Prochlorperazine—Hypotension—Fluorouracil—breast cancer	9.65e-05	0.000514	CcSEcCtD
Prochlorperazine—Leukopenia—Paclitaxel—breast cancer	9.65e-05	0.000514	CcSEcCtD
Prochlorperazine—Rash—Tamoxifen—breast cancer	9.64e-05	0.000514	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vinorelbine—breast cancer	9.63e-05	0.000513	CcSEcCtD
Prochlorperazine—Dermatitis—Tamoxifen—breast cancer	9.63e-05	0.000513	CcSEcCtD
Prochlorperazine—Dyspnoea—Mitoxantrone—breast cancer	9.61e-05	0.000512	CcSEcCtD
Prochlorperazine—Dyspnoea—Irinotecan—breast cancer	9.61e-05	0.000512	CcSEcCtD
Prochlorperazine—Erythema multiforme—Capecitabine—breast cancer	9.6e-05	0.000512	CcSEcCtD
Prochlorperazine—Somnolence—Mitoxantrone—breast cancer	9.59e-05	0.000511	CcSEcCtD
Prochlorperazine—Somnolence—Irinotecan—breast cancer	9.59e-05	0.000511	CcSEcCtD
Prochlorperazine—Headache—Tamoxifen—breast cancer	9.57e-05	0.00051	CcSEcCtD
Prochlorperazine—Insomnia—Gemcitabine—breast cancer	9.5e-05	0.000506	CcSEcCtD
Prochlorperazine—Asthma—Methotrexate—breast cancer	9.45e-05	0.000504	CcSEcCtD
Prochlorperazine—Rash—Melphalan—breast cancer	9.44e-05	0.000503	CcSEcCtD
Prochlorperazine—Dermatitis—Melphalan—breast cancer	9.43e-05	0.000502	CcSEcCtD
Prochlorperazine—Cough—Paclitaxel—breast cancer	9.4e-05	0.000501	CcSEcCtD
Prochlorperazine—Arrhythmia—Docetaxel—breast cancer	9.37e-05	0.0005	CcSEcCtD
Prochlorperazine—Dyspnoea—Gemcitabine—breast cancer	9.36e-05	0.000499	CcSEcCtD
Prochlorperazine—Eosinophilia—Methotrexate—breast cancer	9.35e-05	0.000499	CcSEcCtD
Prochlorperazine—Insomnia—Fluorouracil—breast cancer	9.34e-05	0.000498	CcSEcCtD
Prochlorperazine—Somnolence—Gemcitabine—breast cancer	9.34e-05	0.000498	CcSEcCtD
Prochlorperazine—Convulsion—Paclitaxel—breast cancer	9.34e-05	0.000498	CcSEcCtD
Prochlorperazine—Pruritus—Vinorelbine—breast cancer	9.25e-05	0.000493	CcSEcCtD
Prochlorperazine—Constipation—Mitoxantrone—breast cancer	9.22e-05	0.000491	CcSEcCtD
Prochlorperazine—Constipation—Irinotecan—breast cancer	9.22e-05	0.000491	CcSEcCtD
Prochlorperazine—Dyspnoea—Fluorouracil—breast cancer	9.21e-05	0.000491	CcSEcCtD
Prochlorperazine—Rash—Goserelin—breast cancer	9.2e-05	0.000491	CcSEcCtD
Prochlorperazine—Hypersensitivity—Thiotepa—breast cancer	9.2e-05	0.00049	CcSEcCtD
Prochlorperazine—Dermatitis—Goserelin—breast cancer	9.2e-05	0.00049	CcSEcCtD
Prochlorperazine—Somnolence—Fluorouracil—breast cancer	9.18e-05	0.000489	CcSEcCtD
Prochlorperazine—Headache—Goserelin—breast cancer	9.15e-05	0.000487	CcSEcCtD
Prochlorperazine—Erythema—Docetaxel—breast cancer	9.13e-05	0.000487	CcSEcCtD
Prochlorperazine—Arrhythmia—Capecitabine—breast cancer	9.07e-05	0.000484	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—breast cancer	9e-05	0.00048	CcSEcCtD
Prochlorperazine—Constipation—Gemcitabine—breast cancer	8.98e-05	0.000479	CcSEcCtD
Prochlorperazine—Pancytopenia—Methotrexate—breast cancer	8.97e-05	0.000478	CcSEcCtD
Prochlorperazine—Dry mouth—Paclitaxel—breast cancer	8.97e-05	0.000478	CcSEcCtD
Prochlorperazine—Erythema—Capecitabine—breast cancer	8.84e-05	0.000471	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—breast cancer	8.84e-05	0.000471	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—breast cancer	8.84e-05	0.000471	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—breast cancer	8.84e-05	0.000471	CcSEcCtD
Prochlorperazine—Pruritus—Thiotepa—breast cancer	8.83e-05	0.000471	CcSEcCtD
Prochlorperazine—Clozapine—CYP1B1—breast cancer	8.83e-05	0.0211	CrCbGaD
Prochlorperazine—Anaphylactic shock—Paclitaxel—breast cancer	8.79e-05	0.000469	CcSEcCtD
Prochlorperazine—Oedema—Paclitaxel—breast cancer	8.79e-05	0.000469	CcSEcCtD
Prochlorperazine—Muscle spasms—Docetaxel—breast cancer	8.78e-05	0.000468	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—breast cancer	8.75e-05	0.000467	CcSEcCtD
Prochlorperazine—Infection—Paclitaxel—breast cancer	8.74e-05	0.000466	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Methotrexate—breast cancer	8.7e-05	0.000464	CcSEcCtD
Prochlorperazine—Mequitazine—CYP2D6—breast cancer	8.65e-05	0.0206	CrCbGaD
Prochlorperazine—Dizziness—Vinorelbine—breast cancer	8.65e-05	0.000461	CcSEcCtD
Prochlorperazine—Alimemazine—CYP3A4—breast cancer	8.62e-05	0.0206	CrCbGaD
Prochlorperazine—Photosensitivity reaction—Methotrexate—breast cancer	8.62e-05	0.00046	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Paclitaxel—breast cancer	8.61e-05	0.000459	CcSEcCtD
Prochlorperazine—Urticaria—Mitoxantrone—breast cancer	8.57e-05	0.000457	CcSEcCtD
Prochlorperazine—Domperidone—CYP2D6—breast cancer	8.55e-05	0.0204	CrCbGaD
Prochlorperazine—Skin disorder—Paclitaxel—breast cancer	8.54e-05	0.000455	CcSEcCtD
Prochlorperazine—Body temperature increased—Irinotecan—breast cancer	8.52e-05	0.000454	CcSEcCtD
Prochlorperazine—Body temperature increased—Mitoxantrone—breast cancer	8.52e-05	0.000454	CcSEcCtD
Prochlorperazine—Muscle spasms—Capecitabine—breast cancer	8.5e-05	0.000453	CcSEcCtD
Prochlorperazine—Drowsiness—Methotrexate—breast cancer	8.42e-05	0.000449	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—breast cancer	8.4e-05	0.000447	CcSEcCtD
Prochlorperazine—Vision blurred—Capecitabine—breast cancer	8.33e-05	0.000444	CcSEcCtD
Prochlorperazine—Body temperature increased—Gemcitabine—breast cancer	8.3e-05	0.000443	CcSEcCtD
Prochlorperazine—Tremor—Capecitabine—breast cancer	8.28e-05	0.000442	CcSEcCtD
Prochlorperazine—Dizziness—Thiotepa—breast cancer	8.26e-05	0.00044	CcSEcCtD
Prochlorperazine—Rash—Vinorelbine—breast cancer	8.24e-05	0.000439	CcSEcCtD
Prochlorperazine—Dermatitis—Vinorelbine—breast cancer	8.24e-05	0.000439	CcSEcCtD
Prochlorperazine—Hypotension—Paclitaxel—breast cancer	8.22e-05	0.000438	CcSEcCtD
Prochlorperazine—Urticaria—Fluorouracil—breast cancer	8.2e-05	0.000437	CcSEcCtD
Prochlorperazine—Headache—Vinorelbine—breast cancer	8.19e-05	0.000437	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—breast cancer	8.18e-05	0.000436	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—breast cancer	8.18e-05	0.000436	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—breast cancer	8.18e-05	0.000436	CcSEcCtD
Prochlorperazine—Leukopenia—Docetaxel—breast cancer	8.18e-05	0.000436	CcSEcCtD
Prochlorperazine—Body temperature increased—Fluorouracil—breast cancer	8.16e-05	0.000435	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—breast cancer	8.1e-05	0.000432	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—breast cancer	8.07e-05	0.00043	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—breast cancer	8.05e-05	0.000429	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—breast cancer	7.98e-05	0.000425	CcSEcCtD
Prochlorperazine—Cough—Docetaxel—breast cancer	7.97e-05	0.000425	CcSEcCtD
Prochlorperazine—Insomnia—Paclitaxel—breast cancer	7.95e-05	0.000424	CcSEcCtD
Prochlorperazine—Hypersensitivity—Mitoxantrone—breast cancer	7.94e-05	0.000423	CcSEcCtD
Prochlorperazine—Hypersensitivity—Irinotecan—breast cancer	7.94e-05	0.000423	CcSEcCtD
Prochlorperazine—Leukopenia—Capecitabine—breast cancer	7.92e-05	0.000422	CcSEcCtD
Prochlorperazine—Convulsion—Docetaxel—breast cancer	7.91e-05	0.000422	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—breast cancer	7.88e-05	0.00042	CcSEcCtD
Prochlorperazine—Rash—Thiotepa—breast cancer	7.87e-05	0.00042	CcSEcCtD
Prochlorperazine—Dermatitis—Thiotepa—breast cancer	7.87e-05	0.000419	CcSEcCtD
Prochlorperazine—Agranulocytosis—Methotrexate—breast cancer	7.86e-05	0.000419	CcSEcCtD
Prochlorperazine—Dyspnoea—Paclitaxel—breast cancer	7.84e-05	0.000418	CcSEcCtD
Prochlorperazine—Headache—Thiotepa—breast cancer	7.82e-05	0.000417	CcSEcCtD
Prochlorperazine—Somnolence—Paclitaxel—breast cancer	7.82e-05	0.000417	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—breast cancer	7.77e-05	0.000414	CcSEcCtD
Prochlorperazine—Cough—Capecitabine—breast cancer	7.72e-05	0.000411	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—breast cancer	7.68e-05	0.00041	CcSEcCtD
Prochlorperazine—Hypersensitivity—Fluorouracil—breast cancer	7.61e-05	0.000406	CcSEcCtD
Prochlorperazine—Dry mouth—Docetaxel—breast cancer	7.6e-05	0.000405	CcSEcCtD
Prochlorperazine—Constipation—Paclitaxel—breast cancer	7.52e-05	0.000401	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—breast cancer	7.47e-05	0.000398	CcSEcCtD
Prochlorperazine—Oedema—Docetaxel—breast cancer	7.45e-05	0.000397	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Docetaxel—breast cancer	7.45e-05	0.000397	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—breast cancer	7.45e-05	0.000397	CcSEcCtD
Prochlorperazine—Pruritus—Gemcitabine—breast cancer	7.43e-05	0.000396	CcSEcCtD
Prochlorperazine—Mequitazine—CYP3A4—breast cancer	7.42e-05	0.0177	CrCbGaD
Prochlorperazine—Infection—Docetaxel—breast cancer	7.41e-05	0.000395	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—breast cancer	7.38e-05	0.000393	CcSEcCtD
Prochlorperazine—Dry mouth—Capecitabine—breast cancer	7.36e-05	0.000392	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—breast cancer	7.36e-05	0.000392	CcSEcCtD
Prochlorperazine—Domperidone—CYP3A4—breast cancer	7.33e-05	0.0175	CrCbGaD
Prochlorperazine—Pruritus—Fluorouracil—breast cancer	7.31e-05	0.000389	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Docetaxel—breast cancer	7.3e-05	0.000389	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—breast cancer	7.29e-05	0.000389	CcSEcCtD
Prochlorperazine—Skin disorder—Docetaxel—breast cancer	7.24e-05	0.000386	CcSEcCtD
Prochlorperazine—Oedema—Capecitabine—breast cancer	7.22e-05	0.000385	CcSEcCtD
Prochlorperazine—Infection—Capecitabine—breast cancer	7.17e-05	0.000382	CcSEcCtD
Prochlorperazine—Erythema multiforme—Methotrexate—breast cancer	7.15e-05	0.000381	CcSEcCtD
Prochlorperazine—Zuclopenthixol—CYP2D6—breast cancer	7.14e-05	0.017	CrCbGaD
Prochlorperazine—Dizziness—Irinotecan—breast cancer	7.13e-05	0.00038	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—breast cancer	7.11e-05	0.000379	CcSEcCtD
Prochlorperazine—Nefazodone—CYP2D6—breast cancer	7.1e-05	0.0169	CrCbGaD
Prochlorperazine—Thrombocytopenia—Capecitabine—breast cancer	7.07e-05	0.000377	CcSEcCtD
Prochlorperazine—Skin disorder—Capecitabine—breast cancer	7.01e-05	0.000374	CcSEcCtD
Prochlorperazine—Urticaria—Paclitaxel—breast cancer	6.99e-05	0.000372	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—breast cancer	6.97e-05	0.000372	CcSEcCtD
Prochlorperazine—Hypotension—Docetaxel—breast cancer	6.97e-05	0.000371	CcSEcCtD
Prochlorperazine—Body temperature increased—Paclitaxel—breast cancer	6.95e-05	0.000371	CcSEcCtD
Prochlorperazine—Dizziness—Fluorouracil—breast cancer	6.83e-05	0.000364	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—breast cancer	6.81e-05	0.000363	CcSEcCtD
Prochlorperazine—Rash—Mitoxantrone—breast cancer	6.8e-05	0.000362	CcSEcCtD
Prochlorperazine—Rash—Irinotecan—breast cancer	6.8e-05	0.000362	CcSEcCtD
Prochlorperazine—Dermatitis—Mitoxantrone—breast cancer	6.79e-05	0.000362	CcSEcCtD
Prochlorperazine—Dermatitis—Irinotecan—breast cancer	6.79e-05	0.000362	CcSEcCtD
Prochlorperazine—Headache—Mitoxantrone—breast cancer	6.76e-05	0.00036	CcSEcCtD
Prochlorperazine—Headache—Irinotecan—breast cancer	6.76e-05	0.00036	CcSEcCtD
Prochlorperazine—Hypotension—Capecitabine—breast cancer	6.74e-05	0.000359	CcSEcCtD
Prochlorperazine—Insomnia—Docetaxel—breast cancer	6.74e-05	0.000359	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—breast cancer	6.69e-05	0.000357	CcSEcCtD
Prochlorperazine—Dyspnoea—Docetaxel—breast cancer	6.65e-05	0.000354	CcSEcCtD
Prochlorperazine—Somnolence—Docetaxel—breast cancer	6.63e-05	0.000353	CcSEcCtD
Prochlorperazine—Rash—Gemcitabine—breast cancer	6.62e-05	0.000353	CcSEcCtD
Prochlorperazine—Dermatitis—Gemcitabine—breast cancer	6.62e-05	0.000353	CcSEcCtD
Prochlorperazine—Aripiprazole—CYP2D6—breast cancer	6.6e-05	0.0157	CrCbGaD
Prochlorperazine—Erythema—Methotrexate—breast cancer	6.58e-05	0.000351	CcSEcCtD
Prochlorperazine—Headache—Gemcitabine—breast cancer	6.58e-05	0.000351	CcSEcCtD
Prochlorperazine—Trazodone—CYP2D6—breast cancer	6.57e-05	0.0157	CrCbGaD
Prochlorperazine—Insomnia—Capecitabine—breast cancer	6.53e-05	0.000348	CcSEcCtD
Prochlorperazine—Rash—Fluorouracil—breast cancer	6.51e-05	0.000347	CcSEcCtD
Prochlorperazine—Dermatitis—Fluorouracil—breast cancer	6.51e-05	0.000347	CcSEcCtD
Prochlorperazine—Hypersensitivity—Paclitaxel—breast cancer	6.48e-05	0.000345	CcSEcCtD
Prochlorperazine—Headache—Fluorouracil—breast cancer	6.47e-05	0.000345	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—breast cancer	6.45e-05	0.000344	CcSEcCtD
Prochlorperazine—Dyspnoea—Capecitabine—breast cancer	6.43e-05	0.000343	CcSEcCtD
Prochlorperazine—Constipation—Docetaxel—breast cancer	6.37e-05	0.00034	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—breast cancer	6.32e-05	0.000337	CcSEcCtD
Prochlorperazine—Pruritus—Paclitaxel—breast cancer	6.22e-05	0.000332	CcSEcCtD
Prochlorperazine—Vision blurred—Methotrexate—breast cancer	6.2e-05	0.000331	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—breast cancer	6.19e-05	0.00033	CcSEcCtD
Prochlorperazine—Constipation—Capecitabine—breast cancer	6.17e-05	0.000329	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—breast cancer	6.16e-05	0.000328	CcSEcCtD
Prochlorperazine—Thiothixene—CYP2D6—breast cancer	6.16e-05	0.0147	CrCbGaD
Prochlorperazine—Pipotiazine—CYP2D6—breast cancer	6.16e-05	0.0147	CrCbGaD
Prochlorperazine—Domperidone—ABCB1—breast cancer	6.1e-05	0.0146	CrCbGaD
Prochlorperazine—Nefazodone—CYP3A4—breast cancer	6.09e-05	0.0145	CrCbGaD
Prochlorperazine—Chlorpromazine—BCHE—breast cancer	6.08e-05	0.0145	CrCbGaD
Prochlorperazine—Mesoridazine—CYP2D6—breast cancer	6.08e-05	0.0145	CrCbGaD
Prochlorperazine—Nervousness—Epirubicin—breast cancer	5.98e-05	0.000319	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—breast cancer	5.92e-05	0.000316	CcSEcCtD
Prochlorperazine—Body temperature increased—Docetaxel—breast cancer	5.89e-05	0.000314	CcSEcCtD
Prochlorperazine—Leukopenia—Methotrexate—breast cancer	5.89e-05	0.000314	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—breast cancer	5.85e-05	0.000312	CcSEcCtD
Prochlorperazine—Dizziness—Paclitaxel—breast cancer	5.82e-05	0.00031	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—breast cancer	5.81e-05	0.000309	CcSEcCtD
Prochlorperazine—Cough—Methotrexate—breast cancer	5.74e-05	0.000306	CcSEcCtD
Prochlorperazine—Urticaria—Capecitabine—breast cancer	5.73e-05	0.000306	CcSEcCtD
Prochlorperazine—Body temperature increased—Capecitabine—breast cancer	5.71e-05	0.000304	CcSEcCtD
Prochlorperazine—Convulsion—Methotrexate—breast cancer	5.7e-05	0.000304	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—breast cancer	5.7e-05	0.000304	CcSEcCtD
Prochlorperazine—Aripiprazole—CYP3A4—breast cancer	5.66e-05	0.0135	CrCbGaD
Prochlorperazine—Agitation—Epirubicin—breast cancer	5.66e-05	0.000302	CcSEcCtD
Prochlorperazine—Trazodone—CYP3A4—breast cancer	5.63e-05	0.0134	CrCbGaD
Prochlorperazine—Rash—Paclitaxel—breast cancer	5.54e-05	0.000296	CcSEcCtD
Prochlorperazine—Dermatitis—Paclitaxel—breast cancer	5.54e-05	0.000295	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—breast cancer	5.54e-05	0.000295	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—breast cancer	5.51e-05	0.000294	CcSEcCtD
Prochlorperazine—Headache—Paclitaxel—breast cancer	5.51e-05	0.000294	CcSEcCtD
Prochlorperazine—Hypersensitivity—Docetaxel—breast cancer	5.49e-05	0.000293	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—breast cancer	5.48e-05	0.000292	CcSEcCtD
Prochlorperazine—Cough—Epirubicin—breast cancer	5.38e-05	0.000287	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Methotrexate—breast cancer	5.37e-05	0.000286	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—breast cancer	5.37e-05	0.000286	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—breast cancer	5.34e-05	0.000284	CcSEcCtD
Prochlorperazine—Infection—Methotrexate—breast cancer	5.34e-05	0.000284	CcSEcCtD
Prochlorperazine—Mianserin—CYP2D6—breast cancer	5.32e-05	0.0127	CrCbGaD
Prochlorperazine—Fluphenazine—CYP2D6—breast cancer	5.32e-05	0.0127	CrCbGaD
Prochlorperazine—Hypersensitivity—Capecitabine—breast cancer	5.32e-05	0.000283	CcSEcCtD
Prochlorperazine—Clobazam—CYP3A4—breast cancer	5.28e-05	0.0126	CrCbGaD
Prochlorperazine—Pipotiazine—CYP3A4—breast cancer	5.28e-05	0.0126	CrCbGaD
Prochlorperazine—Pruritus—Docetaxel—breast cancer	5.27e-05	0.000281	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Methotrexate—breast cancer	5.26e-05	0.00028	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—breast cancer	5.24e-05	0.000279	CcSEcCtD
Prochlorperazine—Skin disorder—Methotrexate—breast cancer	5.22e-05	0.000278	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—breast cancer	5.13e-05	0.000273	CcSEcCtD
Prochlorperazine—Pruritus—Capecitabine—breast cancer	5.11e-05	0.000272	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—breast cancer	5.1e-05	0.000272	CcSEcCtD
Prochlorperazine—Nefazodone—ABCB1—breast cancer	5.07e-05	0.0121	CrCbGaD
Prochlorperazine—Oedema—Epirubicin—breast cancer	5.03e-05	0.000268	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—breast cancer	5.03e-05	0.000268	CcSEcCtD
Prochlorperazine—Hypotension—Methotrexate—breast cancer	5.02e-05	0.000268	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—breast cancer	4.99e-05	0.000266	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—breast cancer	4.97e-05	0.000265	CcSEcCtD
Prochlorperazine—Triflupromazine—ABCB1—breast cancer	4.94e-05	0.0118	CrCbGaD
Prochlorperazine—Convulsion—Doxorubicin—breast cancer	4.94e-05	0.000263	CcSEcCtD
Prochlorperazine—Dizziness—Docetaxel—breast cancer	4.93e-05	0.000263	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—breast cancer	4.92e-05	0.000262	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—breast cancer	4.88e-05	0.00026	CcSEcCtD
Prochlorperazine—Clomipramine—CYP2D6—breast cancer	4.87e-05	0.0116	CrCbGaD
Prochlorperazine—Insomnia—Methotrexate—breast cancer	4.86e-05	0.000259	CcSEcCtD
Prochlorperazine—Acepromazine—ALB—breast cancer	4.79e-05	0.0114	CrCbGaD
Prochlorperazine—Dyspnoea—Methotrexate—breast cancer	4.79e-05	0.000255	CcSEcCtD
Prochlorperazine—Somnolence—Methotrexate—breast cancer	4.78e-05	0.000255	CcSEcCtD
Prochlorperazine—Dizziness—Capecitabine—breast cancer	4.77e-05	0.000254	CcSEcCtD
Prochlorperazine—Clozapine—CYP1A1—breast cancer	4.77e-05	0.0114	CrCbGaD
Prochlorperazine—Dry mouth—Doxorubicin—breast cancer	4.75e-05	0.000253	CcSEcCtD
Prochlorperazine—Aripiprazole—ABCB1—breast cancer	4.71e-05	0.0112	CrCbGaD
Prochlorperazine—Rash—Docetaxel—breast cancer	4.7e-05	0.00025	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—breast cancer	4.7e-05	0.00025	CcSEcCtD
Prochlorperazine—Dermatitis—Docetaxel—breast cancer	4.7e-05	0.00025	CcSEcCtD
Prochlorperazine—Trazodone—ABCB1—breast cancer	4.69e-05	0.0112	CrCbGaD
Prochlorperazine—Thioproperazine—ALB—breast cancer	4.68e-05	0.0112	CrCbGaD
Prochlorperazine—Headache—Docetaxel—breast cancer	4.67e-05	0.000249	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—breast cancer	4.65e-05	0.000248	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—breast cancer	4.65e-05	0.000248	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—breast cancer	4.62e-05	0.000246	CcSEcCtD
Prochlorperazine—Thiothixene—ALB—breast cancer	4.61e-05	0.011	CrCbGaD
Prochlorperazine—Pipotiazine—ALB—breast cancer	4.61e-05	0.011	CrCbGaD
Prochlorperazine—Thioridazine—CYP2D6—breast cancer	4.58e-05	0.0109	CrCbGaD
Prochlorperazine—Mianserin—CYP3A4—breast cancer	4.56e-05	0.0109	CrCbGaD
Prochlorperazine—Thrombocytopenia—Doxorubicin—breast cancer	4.55e-05	0.000243	CcSEcCtD
Prochlorperazine—Rash—Capecitabine—breast cancer	4.55e-05	0.000243	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—breast cancer	4.55e-05	0.000242	CcSEcCtD
Prochlorperazine—Dermatitis—Capecitabine—breast cancer	4.55e-05	0.000242	CcSEcCtD
Prochlorperazine—Headache—Capecitabine—breast cancer	4.52e-05	0.000241	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—breast cancer	4.52e-05	0.000241	CcSEcCtD
Prochlorperazine—Dyspnoea—Epirubicin—breast cancer	4.48e-05	0.000239	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—breast cancer	4.47e-05	0.000238	CcSEcCtD
Prochlorperazine—Clobazam—ABCB1—breast cancer	4.4e-05	0.0105	CrCbGaD
Prochlorperazine—Methotrimeprazine—CYP2D6—breast cancer	4.38e-05	0.0104	CrCbGaD
Prochlorperazine—Hypotension—Doxorubicin—breast cancer	4.35e-05	0.000232	CcSEcCtD
Prochlorperazine—Promethazine—CYP2D6—breast cancer	4.31e-05	0.0103	CrCbGaD
Prochlorperazine—Constipation—Epirubicin—breast cancer	4.3e-05	0.000229	CcSEcCtD
Prochlorperazine—Urticaria—Methotrexate—breast cancer	4.27e-05	0.000227	CcSEcCtD
Prochlorperazine—Body temperature increased—Methotrexate—breast cancer	4.25e-05	0.000226	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—breast cancer	4.21e-05	0.000224	CcSEcCtD
Prochlorperazine—Perphenazine—CYP2D6—breast cancer	4.21e-05	0.01	CrCbGaD
Prochlorperazine—Clomipramine—CYP3A4—breast cancer	4.17e-05	0.00995	CrCbGaD
Prochlorperazine—Dyspnoea—Doxorubicin—breast cancer	4.15e-05	0.000221	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—breast cancer	4.14e-05	0.00022	CcSEcCtD
Prochlorperazine—Quetiapine—CYP2D6—breast cancer	4.13e-05	0.00984	CrCbGaD
Prochlorperazine—Urticaria—Epirubicin—breast cancer	3.99e-05	0.000213	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—breast cancer	3.98e-05	0.000212	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—breast cancer	3.97e-05	0.000212	CcSEcCtD
Prochlorperazine—Hypersensitivity—Methotrexate—breast cancer	3.96e-05	0.000211	CcSEcCtD
Prochlorperazine—Desipramine—CYP2D6—breast cancer	3.92e-05	0.00934	CrCbGaD
Prochlorperazine—Pruritus—Methotrexate—breast cancer	3.8e-05	0.000203	CcSEcCtD
Prochlorperazine—Fluphenazine—ABCB1—breast cancer	3.8e-05	0.00906	CrCbGaD
Prochlorperazine—Hypersensitivity—Epirubicin—breast cancer	3.7e-05	0.000197	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—breast cancer	3.7e-05	0.000197	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—breast cancer	3.68e-05	0.000196	CcSEcCtD
Prochlorperazine—Clomipramine—ALB—breast cancer	3.64e-05	0.00868	CrCbGaD
Prochlorperazine—Perphenazine—CYP3A4—breast cancer	3.61e-05	0.00861	CrCbGaD
Prochlorperazine—Pruritus—Epirubicin—breast cancer	3.56e-05	0.00019	CcSEcCtD
Prochlorperazine—Dizziness—Methotrexate—breast cancer	3.55e-05	0.000189	CcSEcCtD
Prochlorperazine—Clozapine—CYP2D6—breast cancer	3.55e-05	0.00846	CrCbGaD
Prochlorperazine—Quetiapine—CYP3A4—breast cancer	3.54e-05	0.00844	CrCbGaD
Prochlorperazine—Clomipramine—ABCB1—breast cancer	3.47e-05	0.00829	CrCbGaD
Prochlorperazine—Chlorprothixene—ABCB1—breast cancer	3.46e-05	0.00825	CrCbGaD
Prochlorperazine—Hypersensitivity—Doxorubicin—breast cancer	3.43e-05	0.000183	CcSEcCtD
Prochlorperazine—Rash—Methotrexate—breast cancer	3.39e-05	0.000181	CcSEcCtD
Prochlorperazine—Dermatitis—Methotrexate—breast cancer	3.38e-05	0.00018	CcSEcCtD
Prochlorperazine—Headache—Methotrexate—breast cancer	3.37e-05	0.000179	CcSEcCtD
Prochlorperazine—Desipramine—CYP3A4—breast cancer	3.36e-05	0.00801	CrCbGaD
Prochlorperazine—Chlorpromazine—CYP2D6—breast cancer	3.34e-05	0.00796	CrCbGaD
Prochlorperazine—Dizziness—Epirubicin—breast cancer	3.32e-05	0.000177	CcSEcCtD
Prochlorperazine—Imipramine—CYP2D6—breast cancer	3.32e-05	0.00792	CrCbGaD
Prochlorperazine—Pruritus—Doxorubicin—breast cancer	3.29e-05	0.000175	CcSEcCtD
Prochlorperazine—Promazine—CYP3A4—breast cancer	3.25e-05	0.00776	CrCbGaD
Prochlorperazine—Rash—Epirubicin—breast cancer	3.17e-05	0.000169	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—breast cancer	3.17e-05	0.000169	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—breast cancer	3.15e-05	0.000168	CcSEcCtD
Prochlorperazine—Promethazine—ABCB1—breast cancer	3.08e-05	0.00734	CrCbGaD
Prochlorperazine—Dizziness—Doxorubicin—breast cancer	3.08e-05	0.000164	CcSEcCtD
Prochlorperazine—Clozapine—CYP3A4—breast cancer	3.04e-05	0.00726	CrCbGaD
Prochlorperazine—Trifluoperazine—ABCB1—breast cancer	3.04e-05	0.00724	CrCbGaD
Prochlorperazine—Quetiapine—ABCB1—breast cancer	2.95e-05	0.00703	CrCbGaD
Prochlorperazine—Rash—Doxorubicin—breast cancer	2.93e-05	0.000156	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—breast cancer	2.93e-05	0.000156	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—breast cancer	2.91e-05	0.000155	CcSEcCtD
Prochlorperazine—Chlorpromazine—CYP3A4—breast cancer	2.86e-05	0.00683	CrCbGaD
Prochlorperazine—Imipramine—CYP3A4—breast cancer	2.85e-05	0.00679	CrCbGaD
Prochlorperazine—Desipramine—ABCB1—breast cancer	2.8e-05	0.00667	CrCbGaD
Prochlorperazine—Clozapine—ABCB1—breast cancer	2.53e-05	0.00604	CrCbGaD
Prochlorperazine—Chlorpromazine—ALB—breast cancer	2.5e-05	0.00596	CrCbGaD
Prochlorperazine—Chlorpromazine—ABCB1—breast cancer	2.38e-05	0.00568	CrCbGaD
Prochlorperazine—Imipramine—ABCB1—breast cancer	2.37e-05	0.00565	CrCbGaD
Prochlorperazine—HRH1—Signaling by GPCR—MAPK3—breast cancer	4.28e-06	7.84e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BRAF—breast cancer	4.28e-06	7.84e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1B—breast cancer	4.28e-06	7.84e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.28e-06	7.84e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTM1—breast cancer	4.28e-06	7.84e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—NCOR1—breast cancer	4.28e-06	7.84e-05	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—breast cancer	4.24e-06	7.76e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	4.22e-06	7.72e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BRAF—breast cancer	4.21e-06	7.7e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CASP3—breast cancer	4.2e-06	7.68e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL2—breast cancer	4.19e-06	7.67e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF1—breast cancer	4.17e-06	7.64e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—breast cancer	4.17e-06	7.63e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT2—breast cancer	4.17e-06	7.63e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP17A1—breast cancer	4.16e-06	7.62e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—breast cancer	4.15e-06	7.6e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BRAF—breast cancer	4.14e-06	7.58e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ENO1—breast cancer	4.12e-06	7.54e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS1—breast cancer	4.12e-06	7.54e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GPX1—breast cancer	4.1e-06	7.51e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF1—breast cancer	4.1e-06	7.5e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT2—breast cancer	4.09e-06	7.49e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCND1—breast cancer	4.08e-06	7.48e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PIK3CA—breast cancer	4.08e-06	7.48e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—JUN—breast cancer	4.08e-06	7.46e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—breast cancer	4.08e-06	7.46e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MDM2—breast cancer	4.07e-06	7.45e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP1A1—breast cancer	4.06e-06	7.43e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RAF1—breast cancer	4.05e-06	7.42e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CTNNB1—breast cancer	4.05e-06	7.41e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2D6—breast cancer	4.04e-06	7.39e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RELA—breast cancer	4.03e-06	7.39e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF1—breast cancer	4.03e-06	7.38e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT2—breast cancer	4.03e-06	7.37e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ERCC2—breast cancer	4.02e-06	7.37e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—breast cancer	4.01e-06	7.34e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ERBB2—breast cancer	4.01e-06	7.34e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CD—breast cancer	4.01e-06	7.33e-05	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	3.97e-06	7.26e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—breast cancer	3.97e-06	7.26e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NCOA2—breast cancer	3.96e-06	7.26e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SERPINE1—breast cancer	3.96e-06	7.25e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CB—breast cancer	3.96e-06	7.24e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MTOR—breast cancer	3.96e-06	7.24e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1A—breast cancer	3.95e-06	7.24e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTEN—breast cancer	3.94e-06	7.22e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CD—breast cancer	3.93e-06	7.2e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—KRAS—breast cancer	3.92e-06	7.18e-05	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	3.9e-06	7.13e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SERPINE1—breast cancer	3.89e-06	7.12e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	3.87e-06	7.09e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MAPK8—breast cancer	3.86e-06	7.06e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—KRAS—breast cancer	3.85e-06	7.05e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—breast cancer	3.85e-06	7.04e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—FASN—breast cancer	3.84e-06	7.04e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	3.83e-06	7.02e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—BCHE—breast cancer	3.83e-06	7.01e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	3.83e-06	7.01e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—breast cancer	3.8e-06	6.96e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—KRAS—breast cancer	3.79e-06	6.94e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MTHFR—breast cancer	3.78e-06	6.93e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NOS3—breast cancer	3.78e-06	6.93e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC5A5—breast cancer	3.78e-06	6.92e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HRAS—breast cancer	3.78e-06	6.92e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NOS3—breast cancer	3.71e-06	6.8e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1B—breast cancer	3.71e-06	6.8e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—breast cancer	3.67e-06	6.72e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SRC—breast cancer	3.66e-06	6.69e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NOS3—breast cancer	3.65e-06	6.69e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NQO1—breast cancer	3.65e-06	6.69e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.65e-06	6.69e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CASP3—breast cancer	3.64e-06	6.66e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL2—breast cancer	3.63e-06	6.65e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—breast cancer	3.62e-06	6.62e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CA—breast cancer	3.6e-06	6.6e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MDM2—breast cancer	3.59e-06	6.57e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RAF1—breast cancer	3.58e-06	6.55e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—breast cancer	3.56e-06	6.52e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RELA—breast cancer	3.56e-06	6.52e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCND1—breast cancer	3.54e-06	6.49e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ERBB2—breast cancer	3.54e-06	6.48e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	3.54e-06	6.48e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—JUN—breast cancer	3.53e-06	6.47e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—breast cancer	3.53e-06	6.46e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MDM2—breast cancer	3.52e-06	6.45e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RAF1—breast cancer	3.51e-06	6.43e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CTNNB1—breast cancer	3.51e-06	6.42e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1B1—breast cancer	3.5e-06	6.41e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RELA—breast cancer	3.5e-06	6.4e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MTOR—breast cancer	3.49e-06	6.39e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CB—breast cancer	3.49e-06	6.39e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CAV1—breast cancer	3.49e-06	6.39e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	3.48e-06	6.37e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ERBB2—breast cancer	3.47e-06	6.36e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MDM2—breast cancer	3.47e-06	6.35e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RAF1—breast cancer	3.45e-06	6.33e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RELA—breast cancer	3.44e-06	6.3e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—breast cancer	3.44e-06	6.3e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.43e-06	6.29e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CB—breast cancer	3.43e-06	6.28e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MTOR—breast cancer	3.43e-06	6.28e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1A—breast cancer	3.43e-06	6.27e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTEN—breast cancer	3.42e-06	6.26e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ERBB2—breast cancer	3.42e-06	6.26e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	3.37e-06	6.18e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MTOR—breast cancer	3.37e-06	6.18e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MAPK3—breast cancer	3.37e-06	6.17e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—breast cancer	3.36e-06	6.14e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK8—breast cancer	3.34e-06	6.12e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NCOA1—breast cancer	3.34e-06	6.12e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—breast cancer	3.34e-06	6.11e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HRAS—breast cancer	3.33e-06	6.1e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—breast cancer	3.29e-06	6.03e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—STK11—breast cancer	3.29e-06	6.03e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.29e-06	6.03e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MYC—breast cancer	3.28e-06	6e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1B—breast cancer	3.28e-06	6e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HRAS—breast cancer	3.27e-06	5.99e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TGFB1—breast cancer	3.27e-06	5.98e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—breast cancer	3.24e-06	5.94e-05	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—breast cancer	3.24e-06	5.93e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HRAS—breast cancer	3.22e-06	5.9e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1B—breast cancer	3.22e-06	5.89e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CASP3—breast cancer	3.21e-06	5.88e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL2—breast cancer	3.21e-06	5.87e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—breast cancer	3.2e-06	5.87e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—breast cancer	3.19e-06	5.84e-05	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—breast cancer	3.18e-06	5.83e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CG—breast cancer	3.18e-06	5.82e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SRC—breast cancer	3.17e-06	5.8e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	3.17e-06	5.8e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CASP3—breast cancer	3.15e-06	5.77e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL2—breast cancer	3.15e-06	5.76e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—breast cancer	3.13e-06	5.74e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	3.13e-06	5.73e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCND1—breast cancer	3.13e-06	5.72e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—JUN—breast cancer	3.12e-06	5.71e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CASP3—breast cancer	3.1e-06	5.68e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL2—breast cancer	3.1e-06	5.67e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CTNNB1—breast cancer	3.1e-06	5.67e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—breast cancer	3.09e-06	5.65e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—breast cancer	3.08e-06	5.64e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCND1—breast cancer	3.07e-06	5.62e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—JUN—breast cancer	3.06e-06	5.61e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—COMT—breast cancer	3.06e-06	5.6e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—breast cancer	3.06e-06	5.6e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTP1—breast cancer	3.05e-06	5.58e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CTNNB1—breast cancer	3.04e-06	5.56e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—breast cancer	3.03e-06	5.56e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KRAS—breast cancer	3.03e-06	5.54e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1A—breast cancer	3.02e-06	5.54e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCND1—breast cancer	3.02e-06	5.53e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTEN—breast cancer	3.02e-06	5.52e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—JUN—breast cancer	3.01e-06	5.52e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HMOX1—breast cancer	3e-06	5.5e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ITPR1—breast cancer	3e-06	5.49e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	2.99e-06	5.48e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—breast cancer	2.98e-06	5.46e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.97e-06	5.44e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTEN—breast cancer	2.96e-06	5.42e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK8—breast cancer	2.95e-06	5.4e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—breast cancer	2.94e-06	5.39e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—breast cancer	2.93e-06	5.37e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	2.92e-06	5.35e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK3—breast cancer	2.92e-06	5.35e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTEN—breast cancer	2.91e-06	5.34e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK8—breast cancer	2.9e-06	5.31e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—breast cancer	2.89e-06	5.29e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ABCB1—breast cancer	2.88e-06	5.28e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK8—breast cancer	2.85e-06	5.22e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—breast cancer	2.84e-06	5.21e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MYC—breast cancer	2.84e-06	5.2e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TGFB1—breast cancer	2.83e-06	5.19e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TYMS—breast cancer	2.83e-06	5.18e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NCOR1—breast cancer	2.8e-06	5.12e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.8e-06	5.12e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTM1—breast cancer	2.8e-06	5.12e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SRC—breast cancer	2.8e-06	5.12e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.79e-06	5.12e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CA—breast cancer	2.78e-06	5.09e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—breast cancer	2.78e-06	5.09e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALB—breast cancer	2.76e-06	5.05e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SRC—breast cancer	2.75e-06	5.03e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—breast cancer	2.73e-06	4.99e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SRC—breast cancer	2.7e-06	4.95e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—breast cancer	2.7e-06	4.94e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—breast cancer	2.69e-06	4.93e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GPX1—breast cancer	2.68e-06	4.91e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—breast cancer	2.68e-06	4.9e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.65e-06	4.86e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—breast cancer	2.65e-06	4.85e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—NOS3—breast cancer	2.64e-06	4.83e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—breast cancer	2.63e-06	4.82e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ERCC2—breast cancer	2.63e-06	4.82e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KRAS—breast cancer	2.63e-06	4.81e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—breast cancer	2.61e-06	4.77e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK3—breast cancer	2.58e-06	4.72e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HRAS—breast cancer	2.57e-06	4.71e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK3—breast cancer	2.53e-06	4.63e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MYC—breast cancer	2.51e-06	4.59e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TGFB1—breast cancer	2.5e-06	4.58e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK3—breast cancer	2.49e-06	4.56e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MTHFR—breast cancer	2.47e-06	4.53e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—breast cancer	2.46e-06	4.51e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MYC—breast cancer	2.46e-06	4.51e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TGFB1—breast cancer	2.46e-06	4.5e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—breast cancer	2.45e-06	4.49e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.44e-06	4.46e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MYC—breast cancer	2.42e-06	4.44e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TGFB1—breast cancer	2.42e-06	4.42e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—breast cancer	2.41e-06	4.42e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	2.41e-06	4.42e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—breast cancer	2.41e-06	4.41e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—breast cancer	2.37e-06	4.34e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—breast cancer	2.33e-06	4.27e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KRAS—breast cancer	2.32e-06	4.24e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CAV1—breast cancer	2.28e-06	4.18e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KRAS—breast cancer	2.27e-06	4.16e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—breast cancer	2.27e-06	4.16e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KRAS—breast cancer	2.24e-06	4.1e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HRAS—breast cancer	2.23e-06	4.09e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—breast cancer	2.14e-06	3.91e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CA—breast cancer	2.13e-06	3.9e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTEN—breast cancer	2.1e-06	3.85e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CA—breast cancer	2.09e-06	3.83e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.08e-06	3.81e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—breast cancer	2.06e-06	3.77e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	2.06e-06	3.77e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—breast cancer	2.02e-06	3.7e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—breast cancer	1.99e-06	3.64e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—breast cancer	1.97e-06	3.61e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HRAS—breast cancer	1.97e-06	3.61e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HRAS—breast cancer	1.93e-06	3.54e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HRAS—breast cancer	1.9e-06	3.48e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—breast cancer	1.88e-06	3.45e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—breast cancer	1.85e-06	3.39e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.83e-06	3.35e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—breast cancer	1.82e-06	3.33e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALB—breast cancer	1.8e-06	3.3e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—breast cancer	1.74e-06	3.18e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NOS3—breast cancer	1.73e-06	3.16e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—breast cancer	1.71e-06	3.13e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—breast cancer	1.68e-06	3.08e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.59e-06	2.92e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—breast cancer	1.58e-06	2.89e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.48e-06	2.72e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTEN—breast cancer	1.38e-06	2.52e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—breast cancer	1.21e-06	2.22e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CA—breast cancer	9.71e-07	1.78e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—breast cancer	7.93e-07	1.45e-05	CbGpPWpGaD
